The use of Dermicol-P35 dermal filler for nonsurgical rhinoplasty.
A growing number of patients with congenital or acquired nasal defects is seeking nonsurgical procedures to correct the appearance of their nose. The use of fillers for the correction of nasal deformities is expanding because of their low risk and reversibility compared with surgery. Dermicol-P35 (Evolence; Ortho Dermatologics, Skillman, NJ) is a novel crosslinked, fibrillar type I collagen isolated from porcine tendons that has not been associated with the same degree of immunogenicity as bovine collagen. The use of Dermicol-P35 in this study of 12 subjects was associated with high tolerance, as well as a high degree of satisfaction.
Cassuto
Daniel
D
Department of Plastic Surgery, University of Catania, Piazza Cinque Giornate 1, Milan, Italy. daniel.cassuto@fastwebnet.it
D000328:Adult; D000818:Animals; D001672:Biocompatible Materials; D003094:Collagen / Q000008:administration & dosage* / Q000737:chemistry; D003357:Cosmetic Techniques; D003432:Cross-Linking Reagents / Q000737:chemistry; D003879:Dermatologic Agents / Q000008:administration & dosage* / Q000737:chemistry; D005260:Female; D006031:Glycosylation; D006801:Humans; D007279:Injections, Subcutaneous; D008297:Male; D008875:Middle Aged; D009667:Nose Deformities, Acquired / Q000628:therapy*; D017060:Patient Satisfaction; D012060:Rejuvenation; D012225:Rhinoplasty / Q000379:methods*; D012266:Ribose / Q000737:chemistry; D013552:Swine; D016896:Treatment Outcome; D055815:Young Adult
D001672:Biocompatible Materials; D003432:Cross-Linking Reagents; D003879:Dermatologic Agents; C530016:dermicol-P35 30G; D012266:Ribose; D003094:Collagen